323 related articles for article (PubMed ID: 25041034)
41. Benefit of measuring basal serum calcitonin to detect medullary thyroid carcinoma in a Danish population with a high prevalence of thyroid nodules.
Hasselgren M; Hegedüs L; Godballe C; Bonnema SJ
Head Neck; 2010 May; 32(5):612-8. PubMed ID: 19691107
[TBL] [Abstract][Full Text] [Related]
42. Mild to moderate increase of serum calcitonin levels only in presence of large medullary thyroid cancer deposits.
Pelizzo MR; Torresan F; Da Roit A; Merante Boschin I; Chondrogiannis S; Rampin L; Colletti PM; Vinjamury S; Perkins AJ; Rubello D
Rev Esp Med Nucl Imagen Mol; 2015; 34(6):378-82. PubMed ID: 26420439
[TBL] [Abstract][Full Text] [Related]
43. Results of surgical treatment of sporadic medullary thyroid carcinoma following routine measurement of serum calcitonin.
Mirallié E; Iacobone M; Sebag F; Henry JF
Eur J Surg Oncol; 2004 Sep; 30(7):790-5. PubMed ID: 15296996
[TBL] [Abstract][Full Text] [Related]
44. Diagnosis of medullary thyroid carcinoma by calcitonin measurement in fine-needle aspiration biopsy specimens.
Kudo T; Miyauchi A; Ito Y; Takamura Y; Amino N; Hirokawa M
Thyroid; 2007 Jul; 17(7):635-8. PubMed ID: 17696833
[TBL] [Abstract][Full Text] [Related]
45. Serum calcitonin negative medullary thyroid carcinoma: a systematic review of the literature.
Trimboli P; Giovanella L
Clin Chem Lab Med; 2015 Sep; 53(10):1507-14. PubMed ID: 25781697
[TBL] [Abstract][Full Text] [Related]
46. RT-PCR-based detection of circulating calcitonin-producing cells in patients with advanced medullary thyroid cancer.
Saller B; Feldmann G; Haupt K; Broecker M; Janssen OE; Roggendorf M; Mann K; Lu M
J Clin Endocrinol Metab; 2002 Jan; 87(1):292-6. PubMed ID: 11788662
[TBL] [Abstract][Full Text] [Related]
47. Usefulness of Serum Calcitonin in Patients Without a Suspicious History of Medullary Thyroid Carcinoma and with Thyroid Nodules Without an Indication for Fine-Needle Aspiration or with Benign Cytology.
Rosario PW; Calsolari MR
Horm Metab Res; 2016 Jun; 48(6):372-276. PubMed ID: 27203410
[TBL] [Abstract][Full Text] [Related]
48. Serum calcitonin levels with calcium loading tests before and after total thyroidectomy in patients with thyroid diseases other than medullary thyroid carcinoma.
Kudo T; Miyauchi A; Ito Y; Yabuta T; Inoue H; Higashiyama T; Tomoda C; Hirokawa M; Amino N
Endocr J; 2011; 58(3):217-21. PubMed ID: 21358115
[TBL] [Abstract][Full Text] [Related]
49. Usefulness of preoperative serum calcitonin in patients with nodular thyroid disease without suspicious history or cytology for medullary thyroid carcinoma.
Rosário PW; Penna GC; Brandão K; Souza BÉ
Arq Bras Endocrinol Metabol; 2013 Jun; 57(4):312-6. PubMed ID: 23828436
[TBL] [Abstract][Full Text] [Related]
50. Presymptomatic thyroidectomy in multiple endocrine neoplasia 2a.
Heizmann O; Haecker FM; Zumsteg U; Müller B; Oberholzer M; Oertli D
Eur J Surg Oncol; 2006 Feb; 32(1):98-102. PubMed ID: 16325365
[TBL] [Abstract][Full Text] [Related]
51. Calcitonin levels in washout samples vs. cytology in the detection of malignant lymph node metastasis in recurrent medullary thyroid cancer.
Gökçay Canpolat A; Şahin M; Ceyhan K; Sak S; Demir Ö; Emral R; Erdoğan MF; Güllü S; Çorapçıoğlu D
Turk J Med Sci; 2021 Dec; 51(6):3061-3066. PubMed ID: 34519193
[TBL] [Abstract][Full Text] [Related]
52. Comparison of calcium and pentagastrin tests for the diagnosis and follow-up of medullary thyroid cancer.
Colombo C; Verga U; Mian C; Ferrero S; Perrino M; Vicentini L; Dazzi D; Opocher G; Pelizzo MR; Beck-Peccoz P; Fugazzola L
J Clin Endocrinol Metab; 2012 Mar; 97(3):905-13. PubMed ID: 22170709
[TBL] [Abstract][Full Text] [Related]
53. Basal and stimulated calcitonin and procalcitonin by various assays in patients with and without medullary thyroid cancer.
Kratzsch J; Petzold A; Raue F; Reinhardt W; Bröcker-Preuss M; Görges R; Mann K; Karges W; Morgenthaler N; Luster M; Reiners C; Thiery J; Dralle H; Fuhrer D
Clin Chem; 2011 Mar; 57(3):467-74. PubMed ID: 21159900
[TBL] [Abstract][Full Text] [Related]
54. Prospects of remission in medullary thyroid carcinoma according to basal calcitonin level.
Machens A; Schneyer U; Holzhausen HJ; Dralle H
J Clin Endocrinol Metab; 2005 Apr; 90(4):2029-34. PubMed ID: 15634717
[TBL] [Abstract][Full Text] [Related]
55. Long-term clinical and biochemical follow-up in medullary thyroid carcinoma: a single institution's experience over 20 years.
Cupisti K; Wolf A; Raffel A; Schott M; Miersch D; Yang Q; Eisenberger CF; Röher HD; Knoefel WT
Ann Surg; 2007 Nov; 246(5):815-21. PubMed ID: 17968174
[TBL] [Abstract][Full Text] [Related]
56. A case of spurious hypercalcitoninemia: a cautionary tale on the use of plasma calcitonin assays in the screening of patients with thyroid nodules for neoplasia.
Uwaifo GI; Remaley AT; Stene M; Reynolds JC; Yen PM; Snider RH; Becker KL; Sarlis NJ
J Endocrinol Invest; 2001 May; 24(5):361-9. PubMed ID: 11407657
[TBL] [Abstract][Full Text] [Related]
57. Calcitonin measurement to detect medullary thyroid carcinoma in nodular goiter: German evidence-based consensus recommendation.
Karges W; Dralle H; Raue F; Mann K; Reiners C; Grussendorf M; Hüfner M; Niederle B; Brabant G;
Exp Clin Endocrinol Diabetes; 2004 Jan; 112(1):52-8. PubMed ID: 14758572
[TBL] [Abstract][Full Text] [Related]
58. Importance of gender-specific calcitonin thresholds in screening for occult sporadic medullary thyroid cancer.
Machens A; Hoffmann F; Sekulla C; Dralle H
Endocr Relat Cancer; 2009 Dec; 16(4):1291-8. PubMed ID: 19726541
[TBL] [Abstract][Full Text] [Related]
59. Changes in risk factors and Tumor Node Metastasis stage of sporadic medullary thyroid carcinoma over 41 years, before and after the routine measurements of serum calcitonin.
Karga H; Giagourta I; Papaioannou G; Doumouchtsis K; Polymeris A; Thanou S; Papamichael K; Zerva C
Metabolism; 2011 May; 60(5):604-8. PubMed ID: 20667564
[TBL] [Abstract][Full Text] [Related]
60. Calcitonin measurements for early detection of medullary thyroid carcinoma or its premalignant conditions in Hashimoto's thyroiditis.
Schuetz M; Beheshti M; Oezer S; Novotny C; Paul M; Hofmann A; Bieglmayer C; Niederle B; Kletter K; Dudczak R; Karanikas G; Pirich C
Anticancer Res; 2006; 26(1B):723-7. PubMed ID: 16739344
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
